Albert Bourla - Apr 10, 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
/s/ Shanice A. Reid, by power of atty., for Albert Bourla
Stock symbol
PFE
Transactions as of
Apr 10, 2025
Transactions value $
$32,040
Form type
4
Date filed
4/14/2025, 03:52 PM
Previous filing
Apr 2, 2025
Next filing
Apr 17, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Award $32K +1.48K +0.21% $21.59 708K Apr 10, 2025 Common Stock 1.48K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.